European Union - English - EMA (European Medicines Agency)

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

European Union - English - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer's disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

zaklady farmaceutyczne polpharma s.a. - latanoprost - eye drops, solution - latanoprost

Malta - English - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics

Malta - English - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

zaklad farmaceutyczny adamed pharma s.a. - risedronate sodium - film-coated tablet - 35 milligram(s) - bisphosphonates; risedronic acid

European Union - English - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

przedsiebiorstwo farmaceutyczne jelfa s.a. - latanoprost timolol maleate - eye drops solution - 50+5

European Union - English - EMA (European Medicines Agency)

"anpharm" przedsiębiorstwo farmaceutyczne s.a. - ivabradine - angina pectoris; heart failure - other cardiac preparations - symptomatic treatment of chronic stable angina pectorisivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated:in adults unable to tolerate or with a contra-indication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal betablocker dose.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Malta - English - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents